Skip to main content

Search form

  • Email Newsletter
  • Podcast

Beta Cells in Diabetes

A resource for physicians established by the Endocrine Society

Main menu

  • Home
  • βCell Science
  • Case Studies
  • Expert Blog
  • Resources
  • CME
  • Podcasts
  • About Us

You are here

Home » Expert Blog » Blog post

Expert Blog

Challenges of Accelerating Treatment to Get to Goal

Posted September 6, 2012 by Doron Schneider, MD, FACP
Tags: 
insulin therapy
Doron Schneider, MD, FACP
General Internist
Biography

 Dr. Doron Schneider, general internist, and Dr. Jack Leahy, endocrinologist, discuss intensifying therapy on a patient who is on two agents with A1C greater than 8.5.

Listen to the podcast or read the transcript

More Posts by this Author

  • How to Assess Second-Line Diabetes Agents for Patients at Risk for Major Osteoporotic Fractures
  • Cholesterol Guidelines: Challenges & Opportunities for Primary Care
  • Sleep Apnea in Patients with Type 2 Diabetes
  • Initial Combination Therapy in a Newly Diagnosed Patient
  • How the Affordable Care Act is Changing the Landscape of Diabetes

Related Content

  • Expert Blog

    The Good, The Bad, and the Ugly Part I: Why I’m not a Fan of the ADA/EASD’s 2012 Position Statement
  • Resource

    One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
  • Podcast

    EDIC: Follow-Up Findings To The Diabetes Control and Complications Trial
  • Resource

    Optimizing Treatment for Patients With Diabetes Mellitus: Glycemic and Nonglycemic Effects
  • Resource

    The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Footer menu

  • RSS Feeds
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Home

BetaCellsInDiabetes.org is a resource for physicians and healthcare professionals.
The information found here is not a substitute for medical advice, diagnosis or treatment.

Endocrine Society